Asia-Pacific has a Record Year for Clinical Trials, according to Novotech CRO
Novotech, the largest biotech CRO in Asia Pacific, says the region has had a record year for clinical trials in terms of the numbers of studies, experienced world-class sites and investigators, and patient enrollment. Novotech released its ‘Asia-Pacific Industry Highlights 2019-2020’ during the annual JP Morgan Healthcare Conference (Jan 7-10) in San Francisco, as part of its biotech industry briefing on the benefits of conducting clinical research in Asia-Pacific. The briefing covered:– Asia’s vast patient pools,– High-quality infrastructure,– Lower trial… Keep Reading
